Elisenda Pons
Overview
Explore the profile of Elisenda Pons including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
420
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Giros A, Grzybowski M, Sohn V, Pons E, Fernandez-Morales J, Xicola R, et al.
Cancer Prev Res (Phila)
. 2009 Jul;
2(8):732-42.
PMID: 19638488
Several studies have suggested that the n-3 fatty acids Docosahexaenoic (DHA) and Eicosapentaenoic (EPA) have an important protective effect on colorectal cancer, and this could be at least partly due...
2.
Jover R, Zapater P, Castells A, Llor X, Andreu M, Cubiella J, et al.
Eur J Cancer
. 2008 Aug;
45(3):365-73.
PMID: 18722765
Aims: The aim of this study is to evaluate if mismatch repair (MMR) defective colorectal cancer has a different response to adjuvant 5-fluorouracil (5-FU) chemotherapy in a cohort of patients...
3.
Bessa X, Belen Balleste , Andreu M, Castells A, Bellosillo B, Balaguer F, et al.
Clin Gastroenterol Hepatol
. 2007 Dec;
6(2):206-14.
PMID: 18096441
Background & Aims: Mismatch repair (MMR) deficiencies are the hallmark of tumors arising in Lynch syndrome, however, in approximately 15% of sporadic colorectal cancers (CRC) these deficiencies most often are...
4.
Belen Balleste , Bessa X, Pinol V, Castellvi-Bel S, Castells A, Alenda C, et al.
Dis Colon Rectum
. 2007 May;
50(7):971-80.
PMID: 17468913
Purpose: Patients with colorectal cancer have a high risk of developing metachronous neoplasms. Identification of predictive factors associated with such conditions would allow individualized follow-up strategies in these patients. This...
5.
Castellvi-Bel S, Castells A, de Cid R, Munoz J, Balaguer F, Gonzalo V, et al.
Carcinogenesis
. 2007 Apr;
28(8):1687-91.
PMID: 17449901
ARLTS1 was recently identified in chromosome 13q14 as a tumor suppressor gene of the ADP-ribosylation factor family with pro-apoptotic characteristics. Additionally, one of its genetic variants (W149X) was hypothesized to...
6.
Bujanda L, Sarasqueta C, Zubiaurre L, Cosme A, Munoz C, Sanchez A, et al.
Gut
. 2007 Apr;
56(12):1714-8.
PMID: 17400596
Background: Colonoscopy is one of the methods of choice for screening relatives of patients with colorectal cancer. Objective: To evaluate the rate of adherence to colonoscopy in first-degree relatives of...
7.
Balaguer F, Castellvi-Bel S, Castells A, Andreu M, Munoz J, Gisbert J, et al.
Clin Gastroenterol Hepatol
. 2007 Mar;
5(3):379-87.
PMID: 17368238
Background & Aims: Whereas it has conclusively been demonstrated that biallelic MutY human homolog (MYH) mutations confer a significant risk for colorectal cancer (CRC), the influence of monoallelic mutations remains...
8.
Xicola R, Llor X, Pons E, Castells A, Alenda C, Pinol V, et al.
J Natl Cancer Inst
. 2007 Feb;
99(3):244-52.
PMID: 17284719
Background: Colorectal tumors caused by failure of the DNA mismatch repair system commonly show microsatellite instability. Our goals were to compare the performance of two panels of markers (a panel...
9.
Castells A, Paya A, Alenda C, Rodriguez-Moranta F, Agrelo R, Andreu M, et al.
Clin Cancer Res
. 2006 Mar;
12(6):1686-92.
PMID: 16551850
Background: Cyclooxygenase 2 (COX-2) overexpression is a frequent but not universal event in colorectal cancer. It has been suggested that COX-2 protein expression is reduced in colorectal cancer with a...
10.
Llor X, Pons E, Xicola R, Castells A, Alenda C, Pinol V, et al.
Clin Cancer Res
. 2005 Oct;
11(20):7304-10.
PMID: 16243801
Purpose: Hereditary nonpolyposis colorectal cancer (HNPCC) is the commonest form of inherited colorectal cancer. Whereas it has been known that mismatch repair gene mutations are the underlying cause of HNPCC,...